Treat rosacea by treating the cause: demodex

Article

Years ago, Mark Dunbar, OD, FAAO, of Bascom Palmer shared with me some cases about rosacea. I was a little taken aback because the cases he shared concerned Hispanic patients, not the usual patients of Northern English isles descent we read about in school. The skeptic in me was doubtful, even though Mark had great pictures and detailed data from the cases.


Years ago, Mark Dunbar, OD, FAAO, of Bascom Palmer shared with me some cases about rosacea.

I was a little taken aback because the cases he shared concerned Hispanic patients, not the usual patients of Northern English isles descent we read about in school.

The skeptic in me was doubtful, even though Mark had great pictures and detailed data from the cases.

Fast forward to today. Dry eyes and lid disease are the main buzzwords in ocular surface. In the past, everyone had aqueous tear deficiency, now everyone has meibomian gland dysfunction (MGD)/evaporative/blepharitis.

With respect to blepharitis, Gary Gerber, OD, says it seems like staphylococcus has left the planet and demodex has taken its place.1

Related: A different approach to treating demodex blepharitis

Demodex and rosacea

So, let’s look at the demodex prevalence studies. Three studies posit the rates of demodex in blepharitis: 62.9 percent, 88 percent, 97 percent of patients with blepharitis have demodex.2-5 The figures are not exactly the same, but they all represent the majority.

There was a time when I believed there was blepharitis and, on a rare occasion, demodex blepharitis. Now, I believe that most blepharitis is actually caused by demodex. Yes, it is that prevalent.

What does this have to do with rosacea? Recent research has pointed to an undeniable link between rosacea and demodex. Meta-analysis of several studies bears this out.5 Demodex even shares the same bacteria as rosacea patients.7,8

Diagnosing demodex

We are aware of the treatments for rosacea, and we know it is a chronic disease. Most of the treatments are palliative; there is no cure. Prescribing several treatments in clinical practice with little to no success is almost the norm.

Based on the studies, I really do think the demodex mite causes rosacea. Our patterns of frustration with rosacea pretty much follow the patterns with demodex. Try this, try that. 

Tea tree oil treatment

We know that the best treatment for demodex is tea tree oil.9 Tea tree oil is merciless against the mite. It comes in pads, ointments, soaps, shampoos, etc. We have noticed it is also effective against rosacea.

Typically, we recommend the patient to use the tea tree oil wipes on their face after using on the lids. The results have been excellent.

Patients for the first time have the redness in their cheeks resolve. The mite does not only reside in the lashes, it also resides in the skin. Our luck in treating rosacea has increased when we think of it as a demodex problem first.

Since learning more about demodex, I am seeing much more rosacea than ever, even in places I would never expect, like my own clinical practice. Because my patient demographic is mostly Hispanic, I am seeing lots of rosacea and demodex in, of course, mostly Hispanics.

Mark Dunbar, you were right all along.

Want more on demodex? Click here!

References

1. Power Hour. http://powerhour.info/demodex-and-blepharitis-where-were-you-5-years-ago. Accessed 1/5/15.

2. Sumer Z, Arıcı MK, Topalkara A, et al. Incidence of Demodex folliculorum in chronic blepharitis patients. Cumhuriyet  Univ Tıp Fak Dergisi. 2000;22:69Y72.


3. Alejo RL, Valenton MJ, Abendanio R. Demodex folliculorum infestation of the lids in Filipinos. Philipp J Ophthalmol. 1972;4:110Y3. ̢۬

4. De Venecia AB, Siong RL. Demodes sp. infestation in anterior blepharitis, meibomian gland dysfunction, and mixed blepharitis. Philipp J Ophthalmol. 2011;36:15Y22.̢۬

5. Zhao YE, Wu LP, Hu L, et al. Association of blepharitis with Demodex: a meta-analysis. Ophthalmic Epidemiol. 2012 Apr;19(2):95-102.

6. Zhao YE, Wu LP, Peng Y, et al. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010 Aug;146(8):896-902.  

7. Li J, O’Reilly N, Sheha H, et al. Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with facial rosacea. Ophthalmology. 2010 May;117(5)870-877.  

8. Jarmuda S, O’Reilly N, Zaba R, et al. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012 Nov;61(Pt. 11):1504-10.

9. Hom M, Mastrota K, Schachter SE. Demodex. Optom Vis Sci. 2013 Jul;90(7):e198-205.

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.